WAY Stock Analysis: Buy, Sell, or Hold?
WAY - Waystar Holding Corp. Common Stock
$17.93
-0.90 (-4.78%)
▼
5d:
-16.14%
30d:
-29.19%
90d:
-19.99%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Smart Money Accumulation
WAY is down 3.8% this week, but smart money is accumulating calls. Top strike: $20 2026-06-18 with 21 OI. Call ratio: 100% View Scanner →
Strength: 6.9/10
Get Alerted When WAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: WAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$42.41
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$26.33
31.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WAY is currently trading at $17.93, which is considered oversold relative to its 30-day fair value range of $20.10 to $25.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.7) compared to its historical average (15.5). Remarkably, the market is currently pricing in an annual earnings decline of 14.5% over the next few years. This pessimistic expectation contrasts with the company's recent 37.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is currently testing key support at $18.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: WAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $34.74 (+93.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is currently testing key support at $18.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: WAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $34.74 (+93.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.10 -
$25.11
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding WAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 93.7% below Wall St target ($34.74)
- CAUTION: 5-day price weakness (-16.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$20.10 -
$25.11
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.19
Resistance Level
$21.60
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.72
Wall Street Target
$34.74
(+93.7%)
Revenue Growth (YoY)
22.4%
Earnings Growth (YoY)
37.5%
Profit Margin
10.9%
Valuation Discount vs History
-14.5% cheaper
PE vs Historical
9.7 vs 15.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.5%
(market-implied from PE analysis)
1-Year Target
$16.14
(-10%)
2-Year Target
$14.52
(-19%)
3-Year Target
$13.07
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→16)
$20.84
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 12.5%)
$57.95
(+223%)
Base:
(SPY PE: 9.7, Growth: 12.5%)
$25.53
(+42%)
Bear:
(PE: 8.3, Growth: 12.5%)
$21.70
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 28.10 | Current EPS (TTM): $0.67
Bull Case
$41.43
(+131%)
Analyst growth 100.0%, PE expands to 30.9
Base Case
$37.66
(+110%)
Market implied 100.0%, PE stable at 28.1
Bear Case
$12.80
(-29%)
Severe decline -20.0%, PE contracts to 23.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 15.5
Stabilization Target:
$28.59
(+59.4%)
PE Expansion Potential:
+59.4%
Share & Embed Analysis
Last updated: May 18, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM
Data refreshes hourly during market hours. Next update: 6:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric L (Ric) Sinclair III
SELL
40225 shares
2026-01-20
Eric L (Ric) Sinclair III
SELL
9701 shares
2025-12-22
Christopher L Schremser
SELL
8623 shares
2025-12-10
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 55 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 52 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 60 HOLD |
Advanced WAY Option Strategies
Professional options setups generated by AI based on today's WAY price and gamma walls.
